Omnia Education

Overcoming Barriers to Talking with Your Patients About Hypoactive Sexual Desire Disorder (HSDD): Screening Tools and Advances in Its Treatment

Overcoming Barriers to Talking with Your Patients About Hypoactive Sexual Desire Disorder (HSDD): Screening Tools and Advances in Its Treatment

Even though HSDD is the most common female sexual dysfunction, it’s persistently underdiagnosed and undermanaged.

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    The underdiagnosis and undermanagement of hypoactive sexual desire disorder is in large part due to clinicians’ reluctance to raise issues of sexual health and functioning in their female patients, in addition to a lack of awareness of diagnostic screeners available and evolving therapeutic approaches. 

    In addition to defining HSDD, this article will also address the barriers that inhibit the appropriate diagnosis and management of HSDD. Also discussed will be the screening tools that allow for diagnosis of HSDD as well as the current therapeutic modalities to manage HSDD.

  • Disclosure of Conflicts of Interest

    Disclosure of Conflicts of Interest: 

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Sheryl A. Kingsberg, PhD

    Chief, Division of Behavioral Medicine
    Department of OB/GYN
    MacDonald Women’s Hospital
    University Hospitals Cleveland Medical Center
    Professor, Departments of Reproductive Biology and Psychiatry
    Case Western Reserve University School of Medicine
    Cleveland, OH

    Consulting Fees: AMAG Pharmaceuticals, Dare, Emotional Brain, Endoceutics, Lupin Pharmaceuticals, Inc., Sprout, Strategic Science Technologies, Therapeutics MD, IVEX Commercial Interest Speakers Bureau: AMAG Pharmaceuticals, Therapeutics MD
    Contracted Research: AMAG Pharmaceuticals, Dare, Endoceutics, Palatin
    Ownership Interest: Viveve

    David J. Portman, MD
    Founder and Director Emeritus
    Columbus Center for Women’s Health Research
    Adjunct Faculty, The Ohio State University
    Department of Obstetrics and Gynecology
    Founder and CEO, Sermonix Pharmaceuticals
    Columbus, OH

    Grant/Research Support: Boehringer Ingelheim, Endoceutics, Palatin Technologies, QuatRx Pharmaceuticals, Shionogi Pharmaceuticals, TherapeuticsMD
    Consultant/Advisory Board: AMAG Pharmaceuticals, Agile Therapeutics, Duchesnay Pharmaceuticals, ITF Pharma
    Commercial Interest Speakers Bureau: AMAG Pharmaceuticals
    Salary and Stockholder: Sermonix Pharmaceuticals

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Barry A. Fiedel has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP has nothing to disclose.
    • Lynne Schneider, PhD has nothing to disclose.
    • Robert Schneider, MSW has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Define hypoactive sexual desire disorder (HSDD)
    • Address barriers that inhibit the appropriate diagnosis and management of HSDD
    • Identify the screening tools that allow for diagnosis of HSDD
    • Identify current therapeutic modalities to manage HSDD
  • Target Audience

    This activity is designed to meet the educational needs of ob/gyn physicians, primary care physicians, nurse practitioners, physician assistants, certified nurse midwives, sex therapists, marriage therapists, and sexuality educators.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant from AMAG Pharmaceuticals.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

Facebook Comments


We’re glad to see you’re enjoying Omnia Education…
but how about a more personalized experience?

Register for free